SYROS PHARMACEUTICALS INC's ticker is and the CUSIP is 87184Q206. A total of 50 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,851,560 | +25.4% | 721,914 | 0.0% | 0.01% | +20.0% |
| Q2 2023 | $2,274,029 | +18.0% | 721,914 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $1,927,510 | -25.6% | 721,914 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $2,591,671 | -44.3% | 721,914 | 0.0% | 0.01% | -50.0% |
| Q3 2022 | $4,649,000 | – | 721,914 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 1,299,359 | $5,119,170 | 2.03% |
| Samsara BioCapital, LLC | 881,450 | $3,481,728 | 1.07% |
| Bain Capital Life Sciences Investors, LLC | 2,124,694 | $8,392,541 | 0.94% |
| Omega Fund Management, LLC | 251,270 | $992,517 | 0.91% |
| DAFNA Capital Management LLC | 265,878 | $1,050,218 | 0.33% |
| Flagship Pioneering Inc. | 993,848 | $3,925,700 | 0.28% |
| Avidity Partners Management LP | 1,581,142 | $6,245,511 | 0.25% |
| Artal Group S.A. | 1,475,744 | $5,829 | 0.25% |
| Knott David M Jr | 105,975 | $419 | 0.16% |
| Deep Track Capital, LP | 828,485 | $3,272,516 | 0.13% |